Site/Sponsor Relationships
Why Institutions Should Consider an Externally Administered IBC
Gene therapy clinical trials require specialized oversight & expertise. Read how institutions can prep for the boom in gene therapy research.
Study Activation: Top Four Takeaways from Research Sites
How can sponsors leverage their relationship with their sites to ensure more efficient research?
Site-Driven Metrics: Operational Data To Improve Research
Most metrics are geared toward sponsors and CROs, find out how this ultimately impacts site research operations
Study Activation Survey Results and What it Means for Sites
In this episode, we review results from Advarra's recent survey and discuss study activation success strategies for sites.
How to Successfully Conduct Virtual Investigator Meetings
Explore best practices to conduct virtual investigator meetings to increase comprehension and expedite site activation.
Cell & Gene Therapy vs Drug Research: What’s the Difference?
In the past year, cell and gene therapy research has exploded. Understand how this field differs from traditional drug development.
Succeed in the New Research Landscape with Site Training Technology
In this webinar, we evaluate critical requirements and advanced workflows life sciences companies should look for in site training technology.
Addressing Barriers to DEI in Clinical Research
A diverse, equitable, & inclusive research environment benefits everyone: trials & the communities alike. How can sites incorporate more DEI?
The Power Of Patient Advocacy In Drug Development
This blog outlines the origins and rise of patient advocacy groups, discussing the milestones in the FDA's acceptance of these groups.
Improving Access to Research for Diverse and Underserved Populations
Increasing diversity and inclusion in research has long been a challenge in the clinical research community. Learn strategies to increase access to clinical trials for all.
Industry-Wide Solutions to Improve Access to Clinical Trials
In this discussion, panelists provide actionable strategies for improving access to clinical research for diverse, underserved populations.
The State of Clinical Trial Activation at Sites
While the study activation process is necessary for all sites to conduct, efficiently coordinating all necessary aspects can be challenging.